CEO of Scynexis Inc (SCYX, Financial) Marco Taglietti bought 100,000 shares of SCYX on 06/24/2016 at an average price of $2.39 a share. The total cost of this purchase was $239,000.
SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs. Scynexis Inc has a market cap of $31.150 million; its shares were traded at around $2.24 with and P/S ratio of 112.00.
For the complete insider trading history of SCYX, click here.
SCYNEXIS Inc is a pharmaceutical company engaged in the discovery, development, and commercialization of novel anti-infectives to address unmet therapeutic needs. Scynexis Inc has a market cap of $31.150 million; its shares were traded at around $2.24 with and P/S ratio of 112.00.
CEO Recent Trades:
- CEO Marco Taglietti bought 100,000 shares of SCYX stock on 06/24/2016 at the average price of 2.39. The price of the stock has decreased by 6.28% since.
CFO Recent Trades:
- CFO Eric Francois bought 15,000 shares of SCYX stock on 06/24/2016 at the average price of 2.39. The price of the stock has decreased by 6.28% since.
Directors and Officers Recent Trades:
- Director Clarence Patrick Machado bought 20,000 shares of SCYX stock on 06/24/2016 at the average price of 2.39. The price of the stock has decreased by 6.28% since.
- Director Guy Macdonald bought 40,000 shares of SCYX stock on 06/24/2016 at the average price of 2.39. The price of the stock has decreased by 6.28% since.
For the complete insider trading history of SCYX, click here.